Brief: Cirrusdx Laboratory Receives Emergency Use Authorization From FDA For Covid-19 Testing
16/04/2020 23:06
April 16 (Reuters) - Seegene Inc 096530.KQ :
* CIRRUSDX LABORATORY RECEIVES EMERGENCY USE AUTHORIZATION
FROM
FDA FOR COVID-19 TESTING
Source text for Eikon: ID:nPn4DZrGNa
Further company coverage: 096530.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier